| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/05/2004 | US6800642 Antipsychotic aminomethyl derivatives of 7,8-dihydro-2,6,9-trioxa-3-aza-cyclopenta[a]naphthalene |
| 10/05/2004 | US6800641 For therapy of schizophrenia, schizoaffective disorder, bipolar disorder, parkinson's disease, l-dopa induced psychoses or dyskinesias, tourette's syndrome, hyperprolactinemia, or addiction to ethanol, nicotine, cocaine |
| 10/05/2004 | US6800640 Antiserotonine agents; central nervous system disorders |
| 10/05/2004 | US6800637 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 10/05/2004 | US6800635 Crystallization from solvent at low temperature or slurrying procedure |
| 10/05/2004 | US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use |
| 10/05/2004 | US6800632 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/05/2004 | US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea |
| 10/05/2004 | US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc. |
| 10/05/2004 | US6800623 A 1,3-dithia-4-aza-acenaphthylene 3,3-dioxide compounds; treating psychological disorders |
| 10/05/2004 | US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 10/05/2004 | US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent |
| 10/05/2004 | US6800470 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/05/2004 | US6800285 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 10/05/2004 | CA2338480C Oral liquid mucoadhesive compositions |
| 10/05/2004 | CA2309439C 3-(3-hydroxyphenyl)-3-amino-propionamide derivatives |
| 10/05/2004 | CA2156024C Synthetic excitatory amino acids |
| 10/05/2004 | CA2128956C Tricyclic diazepine vasopressin antagonists |
| 10/02/2004 | CA2423327A1 Single nucleotide polymorphisms for the diagnosis and treatment of schizophirenia spectrum disorders |
| 09/30/2004 | WO2004083855A1 Method for the identification of cells specifically modulating slow inhibition in the neocortex |
| 09/30/2004 | WO2004083851A2 Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) |
| 09/30/2004 | WO2004083417A1 The transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same |
| 09/30/2004 | WO2004083414A1 Monocyte-origin multipotent cell momc |
| 09/30/2004 | WO2004083375A2 Methods of promoting the differentiation of stem cells |
| 09/30/2004 | WO2004083363A2 Therapeutical use of anti-myelin associated glycoprotein (mag) antibodies |
| 09/30/2004 | WO2004083215A2 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications |
| 09/30/2004 | WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083203A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | WO2004083199A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083195A1 Benzothiazole derivative compounds, compositions and uses |
| 09/30/2004 | WO2004083190A1 Biaryl substituted triazoles as sodium channel blockers |
| 09/30/2004 | WO2004083189A1 Biaryl substituted triazoles as sodium channel blockers |
| 09/30/2004 | WO2004083171A2 Use of pyridin-2-ylmethylamine derivatives for the treatment of chronic neuropathological or psychogenic pain symptoms |
| 09/30/2004 | WO2004083167A1 Sulfamide derivative and medicinal composition thereof |
| 09/30/2004 | WO2004082677A1 Substituted p-diaminobenzene derivatives |
| 09/30/2004 | WO2004082584A2 5ht2c receptor antagonists in the treatment of schizophrenia |
| 09/30/2004 | WO2004082581A2 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 09/30/2004 | WO2004082577A2 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/30/2004 | WO2004082574A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 09/30/2004 | WO2004082573A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4) |
| 09/30/2004 | WO2004082567A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 09/30/2004 | WO2004064912A8 An otorhinological delivery device |
| 09/30/2004 | WO2004055211A3 Compositions and methods for detecting and treating neurodegenerative pathologies |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2004038405A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 09/30/2004 | WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | WO2003068197A8 Method for systemic drug delivery through the nail |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040192961 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating |
| 09/30/2004 | US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
| 09/30/2004 | US20040192901 Using superoxide dismutase to identify modulators for treatment of diabetes, scrapies, transmissible spongiform encephalopathies and alzheimer's diseases |
| 09/30/2004 | US20040192898 Anti-abeta antibodies |
| 09/30/2004 | US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents |
| 09/30/2004 | US20040192783 Use of B-2 bronchodilator drugs |
| 09/30/2004 | US20040192775 Stable carnitine or carnitine acetyl ester; dietetics, nutraceutine, drugs |
| 09/30/2004 | US20040192772 Agent for treating the symptoms of dementia disorders and/or depression |
| 09/30/2004 | US20040192766 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192765 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192764 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192763 Central nervous system disorders; antidepressants; neurodegenative diseases; restless leg syndrome; antiepileptic agents; headaches; hearing disorders |
| 09/30/2004 | US20040192759 Use of nefiracetam for treating neurodegeneration |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192745 Method of treating amytrophic lateral sclerosis using melatonin |
| 09/30/2004 | US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 09/30/2004 | US20040192736 New indoline compounds |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192722 Selective iGluR5 receptor antagonists |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 09/30/2004 | US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering |
| 09/30/2004 | US20040192706 Oral administering; sustained release of ocinaplonin |
| 09/30/2004 | US20040192703 Preferentially substituted calcium channel blockers |
| 09/30/2004 | US20040192698 Alzheimer's disease, antidepressants, antihistamines, psychological disorders, bipolar disorders, anticancer agents, cardiovascular disorders, hypotensive agents, antilipemic agents , anticholesterol agents, antiinflammatory agents |
| 09/30/2004 | US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents |
| 09/30/2004 | US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain |
| 09/30/2004 | US20040192689 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
| 09/30/2004 | US20040192683 Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments |
| 09/30/2004 | US20040192682 1,5-Dihydro-pyrazolo[4,3-c]pyridazin-6-one derivatives; glycogen synthase kinase-3 (CSK) inhibitors; nervous system, psychological, and neurodegenerative disorders; diabetes, psychiatry, multiple sclerosis (MS), myocardial infarction, reperfusion/ischemia, alopecia, and stroke |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040192671 Benzo[d]azepine derivatives as 5-ht6 receptor anatagonists |
| 09/30/2004 | US20040192667 Novel pyrazole analogs acting on cannabinoid receptors |
| 09/30/2004 | US20040192659 Sodium channel blocker binds SS1 or SS2 site of extracellular region; cyclooxygenase inhibitor; side effect reduction; tetrodotoxin or derivative |
| 09/30/2004 | US20040192618 Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use |
| 09/30/2004 | US20040192617 Making gabapentin tannate to treat central nervous system disorders by reacting gabapentin and tannic acid; improves certain organoleptic properties such as taste |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040192579 Administration of the mammal a formulation containing a matrine component and dictamnine in amount effective to deliver daily amount of at least 15 mu mole of a matrine component and at least 0.15 mu mole of dictamnine/kg of body weight to treat cancer |
| 09/30/2004 | US20040191898 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 09/30/2004 | US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders |
| 09/30/2004 | US20040191756 Transgenic rodent for diagnosing and identifying modulator for treatment and prevention inflammatory disorders |
| 09/30/2004 | US20040191334 Use of transhinone derivates as cholinesterase inhibitors in treating related diseases |